Weight Loss News and Research

Latest Weight Loss News and Research

Department of Health acting Secretary stresses need to raise TB awareness

Department of Health acting Secretary Dr. Eli Avila today stressed the need to raise public awareness of tuberculosis, or TB, and the importance of efforts to control—and eventually eliminate—the infectious airborne disease.

24 Mar 2011

American Heart Association: 81.8% of obese women underestimate their weight

Overweight and obese mothers and their children think they weigh less than their actual weight, according to research reported at the American Heart Association's Nutrition, Physical Activity and Metabolism/Cardiovascular Disease Epidemiology and Prevention 2011 Scientific Sessions.

24 Mar 2011

Gastroenterologist directs new Crohn's and Colitis Program at UT Southwestern

Dorothy Stockstill was taking eight pills a day, and her severe abdominal pain and persistent diarrhea weren't improving. The Denton resident had seen multiple physicians throughout the Dallas area. Her attacks were so severe, she couldn't successfully travel from the front of a retail store to the restrooms in back.

23 Mar 2011

New Deloitte report: Consumers spend $363 billion on health care

As health care reform marks its one-year anniversary, a new Deloitte report reveals that consumers are spending $363 billion, or 14.7 percent more, on health care than traditionally reported in official government accounts.

23 Mar 2011

Daily dose of safflower oil can help reduce cardiovascular disease

A daily dose of safflower oil, a common cooking oil, for 16 weeks can improve such health measures as good cholesterol, blood sugar, insulin sensitivity and inflammation in obese postmenopausal women who have Type 2 diabetes, according to new research.

22 Mar 2011

Doubts raised over Lap-Band surgery in the long term: Study

This surgery is based on the principle of placing a silicone band around the top portion of the stomach to restrict food intake. It has become an increasingly popular option in the battle against obesity, but some experts have worried about its safety.

21 Mar 2011

Positive results from GDC-0449 Phase II clinical trial in advanced basal cell carcinoma

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced a positive outcome from a pivotal Phase II clinical trial conducted by Roche and Genentech, Curis' collaborator and a wholly owned member of the Roche Group, of GDC-0449, a first-in-class hedgehog pathway inhibitor, in patients with advanced basal cell carcinoma (BCC).

21 Mar 2011

Genentech's vismodegib Phase II clinical study in advanced basal cell carcinoma meets primary endpoint

Genentech, a member of the Roche Group, today announced that a pivotal Phase II clinical study of its investigational Hedgehog Pathway Inhibitor, vismodegib (RG3616/GDC-0449), showed positive results in people with advanced basal cell carcinoma (aBCC), a particularly severe and debilitating form of skin cancer.

21 Mar 2011

Expert says celebrity addiction stories can serve as warning about drug abuse effects

Stories about celebrities with alleged drug problems make entertaining fodder for the media. But to addiction expert Dr. Gregory Jantz, founder of The Center for Counseling and Health Resources and author of several books on addiction, these well-publicized stories of celebrity drug abuse and addiction can serve as a serious warning.

17 Mar 2011

Experts to review latest research on bariatric surgery at International summit

On March 28, leading experts across multiple disciplines will convene at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes to review the latest research on bariatric surgery as a treatment option.

17 Mar 2011

PsiOxus commences MT-102 Phase II study for treatment of cancer- and age-related wasting

PsiOxus Therapeutics, Ltd. announced initiation of a Phase II study of MT-102, a small molecule therapeutic for the treatment of cancer- and age-related wasting. MT-102 is being developed to reverse the effects of cachexia, a wasting disease that accompanies cancer, heart failure, COPD, renal failure, cirrhosis and rheumatoid arthritis, and that is associated with significant morbidity and mortality.

17 Mar 2011

Packaged beverages now have to list total calorie count, not just the calorie content per serving

Americans may like their drinks "sickeningly sweet" but a new labeling initiative may discourage us from pouring on the unnecessary calories, said Jessica Bartfield, MD, medical weight-loss specialist at Gottlieb Memorial Hospital.

17 Mar 2011

TB risk in infants exposed to infected health worker

Around 200 families have been exposed and probably infected with infectious Tuberculosis (TB) after a hospital health worker was diagnosed with the disease. At present the health care worker is off work and is receiving treatment. The hospital said there was no continuing risk to patients and staff.

16 Mar 2011

Experimental vaccine against human norovirus generates strong, safe immune response in mice

Scientists have shown that an experimental vaccine against the human norovirus - the bug behind about 90 percent of highly contagious nonbacterial illnesses that cause diarrhea and vomiting - can generate a strong immune response in mice without appearing to cause the animals any harm.

16 Mar 2011

Prophylactic PEG placement prior to HNC therapy associated with high rate of non use

Impairment of oral intake occurs in the majority of patients with head and neck cancer (HNC) receiving chemoradiotherapy. Placement of prophylactic percutaneous endoscopic gastrostomy (PEG) tube in asymptomatic newly diagnosed HNC before chemoradiation is a common practice in some centers. In some studies, PEG has been associated with a decrease in treatment related weight loss in patients with HNC, but no studies have examined the utilization rate.

16 Mar 2011

Incyte’s ruxolitinib COMFORT-II Phase III trial in MF meets primary endpoint

COMFORT-II, the second pivotal Phase III trial of Incyte Corporation's investigational Janus kinase inhibitor, ruxolitinib, has met its primary endpoint of significantly reducing spleen size in patients with myelofibrosis, when compared to best available therapy.

15 Mar 2011

Bariatric surgery can lead to long-term weight loss, reduce cardiac risk factors in obese adults

Bariatric surgery can result in long-term weight loss and significant reductions in cardiac and other risk factors for some severely obese adults, according to a scientific statement from the American Heart Association.

15 Mar 2011

Alzheimer's vaccine - First evidence for efficacy

AFFiRiS' Alzheimer's vaccine candidate AD02 showed indicative evidence for potential efficacy in a phase I clinical trial. This was demonstrated by the analysis of the data from secondary clinical study endpoints.

12 Mar 2011

Arena fourth quarter net loss decreases to $28.2 million

Arena Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2010, and reviewed recent developments.

11 Mar 2011

NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for celiac disease

Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH), to support the development of a novel antibody therapeutic for celiac disease.

11 Mar 2011

Weight Loss News and Research

Latest Weight Loss News and Research

Department of Health acting Secretary stresses need to raise TB awareness

American Heart Association: 81.8% of obese women underestimate their weight

Gastroenterologist directs new Crohn's and Colitis Program at UT Southwestern

New Deloitte report: Consumers spend $363 billion on health care

Daily dose of safflower oil can help reduce cardiovascular disease

Doubts raised over Lap-Band surgery in the long term: Study

Positive results from GDC-0449 Phase II clinical trial in advanced basal cell carcinoma

Genentech's vismodegib Phase II clinical study in advanced basal cell carcinoma meets primary endpoint

Expert says celebrity addiction stories can serve as warning about drug abuse effects

Experts to review latest research on bariatric surgery at International summit

PsiOxus commences MT-102 Phase II study for treatment of cancer- and age-related wasting

Packaged beverages now have to list total calorie count, not just the calorie content per serving

TB risk in infants exposed to infected health worker

Experimental vaccine against human norovirus generates strong, safe immune response in mice

Prophylactic PEG placement prior to HNC therapy associated with high rate of non use

Incyte’s ruxolitinib COMFORT-II Phase III trial in MF meets primary endpoint

Bariatric surgery can lead to long-term weight loss, reduce cardiac risk factors in obese adults

Alzheimer's vaccine - First evidence for efficacy

Arena fourth quarter net loss decreases to $28.2 million

NIH awards Avaxia Phase I SBIR grant to develop novel antibody therapeutic for celiac disease

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Weight Loss News and Research

Latest Weight Loss News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in